Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 2
1981 5
1982 3
1983 11
1984 2
1985 5
1986 8
1987 13
1988 8
1989 12
1990 8
1991 10
1992 17
1993 14
1994 20
1995 25
1996 36
1997 46
1998 42
1999 45
2000 44
2001 65
2002 72
2003 95
2004 102
2005 127
2006 123
2007 148
2008 226
2009 293
2010 331
2011 441
2012 478
2013 558
2014 667
2015 718
2016 751
2017 859
2018 972
2019 1119
2020 1308
2021 1472
2022 1854
2023 1872
2024 1969
2025 2175
2026 43

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17,127 results

Results by year

Filters applied: . Clear all
Page 1
Sacituzumab Tirumotecan in EGFR-TKI-Resistant, EGFR-Mutated Advanced NSCLC.
Fang W, Wu L, Meng X, Yao Y, Zuo W, Yao W, Xie Y, Zhang Y, Cui J, Zhang Y, Li X, Zhuang W, Fang J, Wang Q, Jiang W, Li K, Bai Y, Luo Y, Ma F, Yu Y, Zheng W, Liu Z, Yang B, Ma R, Fang Y, Yang R, Jiang L, Hu J, Yang J, Diao Y, Jin X, Ge J, Yang Y, Zhang L. Fang W, et al. Among authors: meng x. N Engl J Med. 2025 Oct 19. doi: 10.1056/NEJMoa2512071. Online ahead of print. N Engl J Med. 2025. PMID: 41124220
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial.
Chen Z, Yang F, Jiang Z, Sun L, Wu L, Han Z, Fan Y, Zhao Y, Li X, Xu H, Meng X, Liu Y, Zhang Z, Luo H, Ma X, Ma X, Shi Q, Zhang Z, Yang R, Wang P, Pan P, Ai X, Li J, Pu X, Wang Z, Fang J, He M, He Y, Guo S, Li J, Wang H, Zhang J, Chu Q, Liu X, Ying S, Wu H, Sun H, Ji Y, Zhou M, Cao C, Tang K, Li Z, Li D, Zhang Z, Li J, Zhou J, Yang H, Du Y, Yang H, Shi J, Chen H, Li W, Lu D, Hu M, Maxwell Wang Z, Li B, Xia M, Lu S. Chen Z, et al. Among authors: meng x. Lancet. 2025 Nov 1;406(10515):2078-2088. doi: 10.1016/S0140-6736(25)01848-3. Epub 2025 Oct 19. Lancet. 2025. PMID: 41125109 Clinical Trial.
Wearable solar fluidic system.
Meng X, Wang X, Yu B, Zhan Q, Tao Z, Liu W, Miao T, Song A, Lu W, Sun Y, Dai Y, Xiong Y. Meng X, et al. Sci Adv. 2025 Oct 31;11(44):eaea1399. doi: 10.1126/sciadv.aea1399. Epub 2025 Oct 29. Sci Adv. 2025. PMID: 41160694 Free PMC article.
Self-directed tool use by giant pandas.
Yang B, Anderson JR, Meng XY, Wang KF, Li BG. Yang B, et al. Among authors: meng xy. Curr Biol. 2025 Oct 20;35(20):R942-R943. doi: 10.1016/j.cub.2025.09.003. Curr Biol. 2025. PMID: 41118730
17,127 results
You have reached the last available page of results. Please see the User Guide for more information.